| ViraEpi760 | Epstein barr virus (EBV) | Wp | NA | 14462 | 14462 | Hyper | 78.57% | Wp-restricted cell line | Oku-BL c.1 cell line | 14 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi761 | Epstein barr virus (EBV) | Wp | NA | 13956 | 13956 | Hyper | 69.23% | Wp-restricted cell line | Sal-BL c.1 cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi762 | Epstein barr virus (EBV) | Wp | NA | 13976 | 13976 | Hyper | 84.61% | Wp-restricted cell line | Sal-BL c.1 cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi764 | Epstein barr virus (EBV) | Wp | NA | 14077 | 14077 | Hyper | 92.30% | Wp-restricted cell line | Sal-BL c.1 cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi765 | Epstein barr virus (EBV) | Wp | NA | 14085 | 14085 | Hyper | 100% | Wp-restricted cell line | Sal-BL c.1 cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi766 | Epstein barr virus (EBV) | Wp | NA | 14101 | 14101 | Hyper | 100% | Wp-restricted cell line | Sal-BL c.1 cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi767 | Epstein barr virus (EBV) | Wp | NA | 14103 | 14103 | Hyper | 100% | Wp-restricted cell line | Sal-BL c.1 cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi768 | Epstein barr virus (EBV) | Wp | NA | 14105 | 14105 | Hyper | 100% | Wp-restricted cell line | Sal-BL c.1 cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi769 | Epstein barr virus (EBV) | Wp | NA | 14115 | 14115 | Hyper | 69.23% | Wp-restricted cell line | Sal-BL c.1 cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi771 | Epstein barr virus (EBV) | Wp | NA | 14161 | 14161 | Hyper | 84.61% | Wp-restricted cell line | Sal-BL c.1 cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi772 | Epstein barr virus (EBV) | Wp | NA | 14259 | 14259 | Hyper | 84.61% | Wp-restricted cell line | Sal-BL c.1 cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi773 | Epstein barr virus (EBV) | Wp | NA | 14261 | 14261 | Hyper | 92.30% | Wp-restricted cell line | Sal-BL c.1 cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi774 | Epstein barr virus (EBV) | Wp | NA | 14288 | 14288 | Hyper | 100% | Wp-restricted cell line | Sal-BL c.1 cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi775 | Epstein barr virus (EBV) | Wp | NA | 14290 | 14290 | Hyper | 100% | Wp-restricted cell line | Sal-BL c.1 cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi776 | Epstein barr virus (EBV) | Wp | NA | 14296 | 14296 | Hyper | 100% | Wp-restricted cell line | Sal-BL c.1 cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi779 | Epstein barr virus (EBV) | Wp | NA | 14445 | 14445 | Hyper | 69.23% | Wp-restricted cell line | Sal-BL c.1 cell line | 13 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi781 | Epstein barr virus (EBV) | Wp | NA | 13956 | 13956 | Hyper | 90% | BL latency I cell line | Awia-BL c.9 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi782 | Epstein barr virus (EBV) | Wp | NA | 13976 | 13976 | Hyper | 100% | BL latency I cell line | Awia-BL c.9 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi784 | Epstein barr virus (EBV) | Wp | NA | 14077 | 14077 | Hyper | 100% | BL latency I cell line | Awia-BL c.9 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi785 | Epstein barr virus (EBV) | Wp | NA | 14085 | 14085 | Hyper | 100% | BL latency I cell line | Awia-BL c.9 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi786 | Epstein barr virus (EBV) | Wp | NA | 14101 | 14101 | Hyper | 100% | BL latency I cell line | Awia-BL c.9 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi787 | Epstein barr virus (EBV) | Wp | NA | 14103 | 14103 | Hyper | 100% | BL latency I cell line | Awia-BL c.9 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi788 | Epstein barr virus (EBV) | Wp | NA | 14105 | 14105 | Hyper | 100% | BL latency I cell line | Awia-BL c.9 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi789 | Epstein barr virus (EBV) | Wp | NA | 14115 | 14115 | Hyper | 80% | BL latency I cell line | Awia-BL c.9 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi790 | Epstein barr virus (EBV) | Wp | NA | 14143 | 14143 | Hyper | 90% | BL latency I cell line | Awia-BL c.9 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 |